A new database, GroceryDB, can show the degree of processing of more than 50,000 food items sold at Walmart, Target, and Whole Foods.

Fifteen candidate genetic variants account for only 0.40 percent of variation in opioid use disorder (OUD) risk, according to a study published online Jan. 9 in ...

Researchers identified 3 distinct PsA phenotype clusters, emphasizing the importance of PsO severity in treatment decision making.

Historical redlining is linked to care utilization and fragmentation among patients with rheumatic conditions, highlighting the role of structural racism in these disparities.

Monthly tralokinumab is an effective dosing regimen for patients with atopic dermatitis who have achieved stable disease control.

The US FDA has amended its color additive regulations to no longer allow the use of FD&C Act Red No. 3 in food and ingested drugs.

After adjusting for demographics, no significant difference in cancer risk was observed for patients with vitiligo and patients without vitiligo.

Using glucocorticoids, rituzimab, or certain immunosuppressants to treat connective tissue diseases is associated with greater risks for severe COVID-19-related outcomes.

Upadacitinib demonstrated long-term efficacy for the treatment of ankylosing spondylitis among patients who failed to respond to prior biologic therapy.

Mistrust in health care and government could explain COVID-19 vaccine hesitancy among Black women in the United States.

Individuals with cutaneous lupus erythematosus have an increased ASCVD risk when compared with those without cutaneous lupus erythematosus.

According to a recent study, there have been shifts in both the patterns and correlates of ketamine use from 2015 to 2022.